アフェレーシス市場レポート：動向、予測、競合分析 (2031年まで)

世界のアフェレーシス市場の将来は、血液センターと病院市場にチャンスがあり、有望です。世界のアフェレーシス市場は、2025年から2031年までのCAGRが7.5%で、2031年までに推定25億米ドルに達すると予想されています。この市場の主な促進要因は、慢性腎疾患の有病率の上昇、献血を奨励する政府キャンペーンの増加、血液成分の需要拡大です。

• Lucintelの予測によると、手法別では、新鮮凍結血漿や充填赤血球などの血液成分の調製に広く採用されている遠心分離が予測期間中最大を維持します。
• 最終用途別では、予測期間中、血液センターがより大きなセグメントであり続けると思われます。
• 地域別では北米が、最先端のアフェレーシスシステムの採用の増加と、同地域の人口における血液関連疾患の罹患率の増加により、予測期間を通じて最大の地域であり続けると思われます。

アフェレーシス市場の戦略的成長機会

アフェレーシス市場は、主要な用途においていくつかの戦略的成長機会を提供しています。これらの機会は、技術の進歩と効果的な治療に対する需要の増加によってもたらされます。

• 腫瘍用途：がん細胞を標的とした新しいアフェレーシス療法が有望な結果を示していることから、腫瘍学用途には大きな成長の可能性があります。がん治療におけるアフェレーシスの利用が拡大しています。
• 自己免疫疾患治療：アフェレーシスは自己免疫疾患の治療にますます使用されるようになっており、患者の転帰を改善する標的療法を提供しています。この用途は市場の主要な成長分野です。
• 新興市場の拡大：新興市場、特にアジア太平洋市場への進出は、医療投資の増加と患者数の増加により、大きな成長機会を提供します。市場参入企業は、これらの地域への進出に注力しています。
• 技術革新：自動化システムやフィルターの改良など、新しいアフェレーシス技術への投資は、治療効率や患者の快適性を高めることで成長機会をもたらします。技術の進歩が市場成長の原動力となっています。
• 規制当局の承認とサポート：新しいアフェレーシス機器や治療法に対する規制当局の承認取得は、革新的なソリューションの導入を促進し、市場範囲を拡大することで成長機会をもたらします。

このような戦略的成長機会は、治療用途の拡大、市場範囲の拡大、技術革新の促進によってアフェレーシス市場を前進させています。企業は市場の潜在力を活用するため、これらの分野に注力しています。

アフェレーシス市場促進要因・課題

アフェレーシス市場は、その成長を形作る様々な促進要因・課題の影響を受けています。技術的進歩、規制要因、経済状況が市場力学において重要な役割を果たします。

アフェレーシス市場を牽引する要因は以下の通りです：

• 技術の進歩：自動化システムやフィルターの改良など、アフェレーシス技術の革新が治療の精度と効率を高め、市場の成長を促進しています。
• 採用の増加：がんや自己免疫疾患など、さまざまな治療用途へのアフェレーシスの採用が増加しており、市場の需要を拡大しています。
• 規制当局のサポート：新しいアフェレーシス機器や治療法に対する規制当局の承認や支援が、技術革新や製品導入を促進し、市場成長を加速しています。
• 医療投資の増加：特に新興市場における医療インフラへの投資の増加が、アフェレーシスサービスと技術の拡大を促進しています。
• 用途の拡大：多様な医療分野でのアフェレーシス利用の拡大が、市場成長とイノベーションの新たな機会を生み出しています。

アフェレーシス市場における課題は以下の通り：

• 高コスト：先進的なアフェレーシス技術や治療には高いコストがかかるため、特に発展途上地域では、アクセスや導入が制限される可能性があります。
• 規制上のハードル：新たなアフェレーシス機器や治療法に関する複雑な規制要件への対応により、製品の承認や市場参入が遅れる可能性があります。
• 製造の複雑さ：アフェレーシス機器や消耗品の製造が複雑であるため、生産規模の拡大や品質の維持に課題があります。

アフェレーシス市場は、技術の進歩、採用の増加、規制当局の支援によって牽引されていますが、高コストや規制上のハードルといった課題に直面しています。市場の成功には、成長促進要因・課題を克服することが不可欠です。

目次

第1章 エグゼクティブサマリー

第2章 世界のアフェレーシス市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界のアフェレーシス市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界のアフェレーシス市場：製品種類別
  • 消耗品・試薬
  • ソフトウェア
  • 装置
• 世界のアフェレーシス市場：手法別
  • 遠心分離
  • 膜分離
  • 選択吸着
• 世界のアフェレーシス市場：処置別
  • ドナー/自動アフェレーシス
  • 治療用アフェレーシス
• 世界のアフェレーシス市場：最終用途別
  • 血液センター
  • 病院
  • その他

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界のアフェレーシス市場：地域別
• 北米のアフェレーシス市場
• 欧州のアフェレーシス市場
• アジア太平洋のアフェレーシス市場
• その他地域のアフェレーシス市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のアフェレーシス市場の成長機会：製品種類別
  • 世界のアフェレーシス市場の成長機会：手法別
  • 世界のアフェレーシス市場の成長機会：処置別
  • 世界のアフェレーシス市場の成長機会：最終用途別
  • 世界のアフェレーシス市場の成長機会：地域別
• 世界のアフェレーシス市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のアフェレーシス市場の生産能力拡大
  • 世界のアフェレーシス市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Kawasumi Laboratories
• Nikkiso
• Haemonetics Corporation
• Asahi Kasei Medical
• Cerus Corporation
• Kaneka Corporation
• Charles River Laboratories International
• B. Braun Melsungen
• Fresenius Kabi
• Terumo BCT

The future of the global apheresis market looks promising with opportunities in the blood center and hospital markets. The global apheresis market is expected to reach an estimated $2.5 billion by 2031 with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the rising prevalence of chronic renal diseases, increasing government campaigns encouraging blood donation, and expanding demand for blood components.

• Lucintel forecasts that, within the method category, the centrifugation segment will remain the largest segment over the forecast period due to its widespread adoption in the preparation of blood components, including fresh frozen plasma and packed red blood cells.
• Within the end use category, blood centers will remain a larger segment over the forecast period.
• In terms of region, North America will remain the largest region over the forecast period due to rising adoption of cutting-edge apheresis systems and growth in the incidence of blood-related illnesses among the population in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Apheresis Market

The apheresis market is influenced by several emerging trends that are transforming the industry. These trends reflect advancements in technology and shifts in treatment approaches, shaping the future of apheresis therapies.

• Technological Advancements: Innovations in apheresis technology, such as automated systems and improved filters, are enhancing treatment precision and patient comfort. These advancements are driving growth by making apheresis more efficient and accessible.
• Expansion in Therapeutic Applications: Apheresis is increasingly used for a wider range of conditions, including autoimmune diseases, cancer, and genetic disorders. This expansion is broadening the market and increasing demand for specialized apheresis therapies.
• Growth in Emerging Markets: Emerging markets, particularly in Asia-Pacific, are experiencing rapid growth in apheresis due to rising healthcare investments and increasing patient populations. This trend is opening new opportunities for market players in these regions.
• Integration of Data Analytics: The use of data analytics and AI in apheresis procedures is improving treatment outcomes and operational efficiency. These technologies are enabling more personalized and effective apheresis treatments.
• Regulatory Support and Approvals: Increasing regulatory approvals and support for new apheresis devices and therapies are accelerating market growth. Governments and health authorities are facilitating the introduction of innovative apheresis solutions.

These trends are reshaping the apheresis market by driving technological advancements, expanding therapeutic applications, and opening new growth opportunities. The focus on innovation and regulatory support is enhancing the effectiveness and reach of apheresis therapies.

Recent Developments in the Apheresis Market

Key developments in the apheresis market reflect technological advancements, regulatory changes, and increasing adoption across various therapeutic areas. These developments are driving growth and expanding the scope of apheresis treatments globally.

• Advanced Apheresis Technologies: New automated apheresis systems with enhanced precision and efficiency have been introduced, improving patient outcomes and treatment consistency. These innovations are setting new standards in the market.
• Regulatory Approvals for New Devices: Recent regulatory approvals for advanced apheresis devices have facilitated market expansion. These approvals are enabling the introduction of new technologies and expanding the range of available apheresis treatments.
• Increased Adoption in Oncology: The use of apheresis in oncology has increased, with new therapies targeting cancer cells showing promising results. This growth reflects a broader application of apheresis in cancer treatment.
• Expansion in Emerging Markets: The apheresis market is expanding rapidly in emerging markets due to increasing healthcare infrastructure and investments. This growth is opening new opportunities for market players and driving global market expansion.
• Innovative Therapeutic Applications: New therapeutic applications of apheresis are being explored, including treatments for autoimmune diseases and genetic disorders. These innovations are broadening the market and increasing demand for apheresis therapies.

These developments are significantly impacting the apheresis market by driving technological advancements, regulatory approvals, and expanding therapeutic applications. The market is growing rapidly due to these innovations and increasing global demand.

Strategic Growth Opportunities for Apheresis Market

The apheresis market offers several strategic growth opportunities across key applications. These opportunities are driven by advancements in technology and increasing demand for effective treatments.

• Oncology Applications: There is significant growth potential in oncology applications, with new apheresis therapies targeting cancer cells showing promising results. This opportunity is expanding the use of apheresis in cancer treatment.
• Autoimmune Disease Treatments: Apheresis is increasingly used for treating autoimmune diseases, providing targeted therapies that improve patient outcomes. This application is a key growth area in the market.
• Emerging Markets Expansion: Expanding into emerging markets, particularly in Asia-Pacific, offers substantial growth opportunities due to rising healthcare investments and increasing patient populations. Market players are focusing on these regions for expansion.
• Technological Innovations: Investing in new apheresis technologies, such as automated systems and improved filters, presents growth opportunities by enhancing treatment efficiency and patient comfort. Technological advancements are driving market growth.
• Regulatory Approvals and Support: Gaining regulatory approvals for new apheresis devices and therapies opens up growth opportunities by facilitating the introduction of innovative solutions and expanding market reach.

These strategic growth opportunities are driving the apheresis market forward by expanding therapeutic applications, increasing market reach, and fostering innovation. Companies are focusing on these areas to capitalize on market potential.

Apheresis Market Driver and Challenges

The apheresis market is influenced by various drivers and challenges that shape its growth. Technological advancements, regulatory factors, and economic conditions play key roles in market dynamics.

The factors responsible for driving the apheresis market include:

• Technological Advancements: Innovations in apheresis technology, including automated systems and improved filters, are enhancing treatment precision and efficiency, driving market growth.
• Increased Adoption: Growing adoption of apheresis for various therapeutic applications, including oncology and autoimmune diseases, is expanding market demand.
• Regulatory Support: Regulatory approvals and support for new apheresis devices and therapies are accelerating market growth by facilitating innovation and product introductions.
• Rising Healthcare Investments: Increased investments in healthcare infrastructure, particularly in emerging markets, are driving the expansion of apheresis services and technologies.
• Expanding Applications: The broadening use of apheresis in diverse medical fields is creating new opportunities for market growth and innovation.

Challenges in the apheresis market are:

• High Costs: The high cost of advanced apheresis technologies and treatments can limit accessibility and adoption, particularly in developing regions.
• Regulatory Hurdles: Navigating complex regulatory requirements for new apheresis devices and therapies can delay product approvals and market entry.
• Manufacturing Complexity: The complexity of manufacturing apheresis equipment and supplies can pose challenges in scaling up production and maintaining quality.

The apheresis market is driven by technological advancements, increased adoption, and regulatory support, but faces challenges such as high costs and regulatory hurdles. Addressing these challenges while capitalizing on growth drivers is crucial for market success.

List of Apheresis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies apheresis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the apheresis companies profiled in this report include-

• Kawasumi Laboratories
• Nikkiso
• Haemonetics Corporation
• Asahi Kasei Medical
• Cerus Corporation
• Kaneka Corporation
• Charles River Laboratories International
• B. Braun Melsungen
• Fresenius Kabi
• Terumo BCT

Apheresis by Segment

The study includes a forecast for the global apheresis market by product type, method, procedure, end use, and region.

Apheresis Market by Product Type [Analysis by Value from 2019 to 2031]:

• Disposable and Reagents
• Software
• Devices

Apheresis Market by Method [Analysis by Value from 2019 to 2031]:

• Centrifugation
• Membrane Separation
• Selective Adsorption

Apheresis Market by Procedure [Analysis by Value from 2019 to 2031]:

• Donor/Automated Apheresis
• Therapeutic Apheresis

Apheresis Market by End Use [Analysis by Value from 2019 to 2031]:

• Blood Centers
• Hospitals
• Others

Apheresis Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Apheresis Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. The below image highlights recent developments by major apheresis producers in key regions: the USA, China, India, Japan, and Germany

• United States: In the U.S., recent developments include the introduction of advanced apheresis technologies and increased adoption of automated systems. Regulatory approvals for new apheresis devices and therapies, particularly for oncology and autoimmune disorders, have accelerated market growth.
• China: China is witnessing significant growth in the apheresis market due to government initiatives supporting healthcare advancements. There is a rise in local manufacturing of apheresis equipment and an increase in clinical applications, particularly for treating blood disorders and cancer.
• Germany: Germany has seen advancements in apheresis technologies, with a focus on improving efficiency and patient comfort. The market is supported by strong healthcare infrastructure and research institutions developing new therapeutic applications for apheresis, especially in hematology and oncology.
• India: In India, the apheresis market is expanding due to increasing healthcare access and investments in medical technology. There is a growing focus on improving apheresis procedures for treating various diseases, supported by government health programs and private sector investments.
• Japan: The Japanese apheresis market is driven by technological innovations and a growing demand for advanced therapeutic solutions. The country is focusing on developing new apheresis technologies and expanding their use in treating chronic diseases and cancer.

Features of the Global Apheresis Market

Market Size Estimates: Apheresis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Apheresis market size by various segments, such as by product type, method, procedure, end use, and region in terms of value ($B).

Regional Analysis: Apheresis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, methods, procedures, end uses, and regions for the apheresis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the apheresis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the apheresis market by product type (disposable and reagents, software, and devices), method (centrifugation, membrane separation, and selective adsorption), procedure (donor/automated apheresis and therapeutic apheresis), end use (blood centers, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Apheresis Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Apheresis Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Apheresis Market by Product Type
  • 3.3.1: Disposable and Reagents
  • 3.3.2: Software
  • 3.3.3: Devices
• 3.4: Global Apheresis Market by Method
  • 3.4.1: Centrifugation
  • 3.4.2: Membrane Separation
  • 3.4.3: Selective Adsorption
• 3.5: Global Apheresis Market by Procedure
  • 3.5.1: Donor/Automated Apheresis
  • 3.5.2: Therapeutic Apheresis
• 3.6: Global Apheresis Market by End Use
  • 3.6.1: Blood Centers
  • 3.6.2: Hospitals
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Apheresis Market by Region
• 4.2: North American Apheresis Market
  • 4.2.1: North American Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.2.2: North American Apheresis Market by End Use: Blood Centers, Hospitals, and Others
• 4.3: European Apheresis Market
  • 4.3.1: European Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.3.2: European Apheresis Market by End Use: Blood Centers, Hospitals, and Others
• 4.4: APAC Apheresis Market
  • 4.4.1: APAC Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.4.2: APAC Apheresis Market by End Use: Blood Centers, Hospitals, and Others
• 4.5: ROW Apheresis Market
  • 4.5.1: ROW Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.5.2: ROW Apheresis Market by End Use: Blood Centers, Hospitals, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Apheresis Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Apheresis Market by Method
  • 6.1.3: Growth Opportunities for the Global Apheresis Market by Procedure
  • 6.1.4: Growth Opportunities for the Global Apheresis Market by End Use
  • 6.1.5: Growth Opportunities for the Global Apheresis Market by Region
• 6.2: Emerging Trends in the Global Apheresis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Apheresis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Apheresis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Kawasumi Laboratories
• 7.2: Nikkiso
• 7.3: Haemonetics Corporation
• 7.4: Asahi Kasei Medical
• 7.5: Cerus Corporation
• 7.6: Kaneka Corporation
• 7.7: Charles River Laboratories International
• 7.8: B. Braun Melsungen
• 7.9: Fresenius Kabi
• 7.10: Terumo BCT